Two co(II)-based coordination polymers: photocatalytic dye degradation properties and treatment effect against colon cancer by inhibiting IL-6-STAT3 inflammatory signaling pathway
JOURNAL OF POLYMER RESEARCH
Authors: Tang, Xiao-Han; Zhang, Ren-Yi; Yang, Yun-Chao; Liu, Wei-Hui; Zhou, Li-Hua
Abstract
Two novel coordination polymers, formulated as {[Co-3(tcpb)(2)(bimb)(DMF)]}(n) (1, bimb = 1,4-bis(imidazol-1-ylmethyl)benene, DMF = N,N-dimethylformamide) and {[Co-2(tcpb)(bim)](DMF)(3)center dot(Dioxane)(2)center dot(H2O)(3)}(n) (2, Hbim = benzimidazole) were prepared from 1,3,5-tris(4-carbonylphenyloxy)benzene (H(3)tcpb), a semi-rigid tripodal carboxylate ligand as well as different N-donor ligands under solvothermal conditions. Due to their excellent water stability, complexes 1 and 2 could be used as catalysts for photocatalytic degradation of dye under the UV irradiation. Furthermore, the protective effect of the compound against colitis-associated colon cancer (CAC) was assessed and the particular mechanism was discussed in this study. Firstly, the real time polymerase chain reaction (PCR) was carried out to determine the il-6 and stat3 relative expression in the colon cancer cells after treated by compounds 1 and 2. Then, the percentage of the colon cancer cells after treated by compounds 1 and 2 was detected via Annexin V-FITC/PI apoptosis assay.
Berberine protects against diabetic retinopathy by inhibiting cell apoptosis via deactivation of the NF-kappa B signaling pathway
MOLECULAR MEDICINE REPORTS
Authors: Zhai, Jiajia; Li, Zeping; Zhang, Huifeng; Ma, Louyan; Ma, Zhengquan; Zhang, Yi; Zou, Jian; Li, Mo; Ma, Li; Wang, Xin; Li, Xiaomiao
Abstract
A number of studies have reported that diabetic retinopathy (DR) is the major cause of blindness. Berberine (BBR) is a bioactive constituent that displays effects on blood glucose; however, the mechanism underlying the role of BBR during the development of DR is not completely understood. In the present study, a rat model of DR was successfully established. The eye tissues were removed and subsequently assessed by hematoxylin and eosin staining and the TUNEL assay. The catalase, malondialdehyde, reactive oxygen species, glutathione and superoxide dismutase contents of the eye tissues were measured. Muller cells were chosen for furtherin vitroexperiments. Cell apoptosis was examined by Annexin V-FITC apoptosis detection and Hoechst staining, and the mitochondrial membrane potential was assessed by JC-1 mitochondrial membrane potential detection. BBR decreased ganglion cell layer, cell apoptosis, reduced diabetic-induced oxidative stress and deactivated the NF-kappa B signaling pathway in the rat model of DR. High glucose enhanced oxidative stress and induced mitochondria-dependent cell apoptosis in Muller cells by activating the NF-kappa B signaling pathway. BBR reversed the high glucose-induced effects by decreasing the phosphorylation of I kappa B, inhibiting NF-kappa B nuclear translocation and deactivating the NF-kappa B signaling pathway. The results suggested that BBR protected against DR by inhibiting oxidative stress and cell apoptosis via deactivation of the NF-kappa B signaling pathway; therefore, suggesting that BBR may serve as a promising therapeutic agent for DR.